drugset / Trial / NCT07500831
Fasting-Mimicking Diet Combined With IO-TKI Combination Therapy in Patients With Metastatic Renal Cell Carcinoma
NaSingle-groupOpen-labelTreatment
Summary
This study is testing whether adding a 5-day fasting-mimicking diet (FMD) can help people with advanced kidney cancer when given together with standard first-line cancer medicines.
Timeline
- Start
- 2026-04
- Primary completion
- 2028-04
- Completion
- 2029-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Background | Axitinib | Small molecule | 5 mg | Oral |
| Background | Toripalimab | Monoclonal antibody | 240 mg | Intravenous |